These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 31096483)
1. Exploring the survival prognosis of lung adenocarcinoma based on the cancer genome atlas database using artificial neural network. Jiang N; Xu X Medicine (Baltimore); 2019 May; 98(20):e15642. PubMed ID: 31096483 [TBL] [Abstract][Full Text] [Related]
2. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma. Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804 [TBL] [Abstract][Full Text] [Related]
3. A novel 14-gene signature for overall survival in lung adenocarcinoma based on the Bayesian hierarchical Cox proportional hazards model. Sun N; Chu J; Hu W; Chen X; Yi N; Shen Y Sci Rep; 2022 Jan; 12(1):27. PubMed ID: 34996932 [TBL] [Abstract][Full Text] [Related]
4. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma. Zou X; Hu Z; Huang C; Chang J Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949 [TBL] [Abstract][Full Text] [Related]
5. [Prognostic study of visceral pleural invasion by pulmonary adenocarcinoma with tumor size ≤3 cm]. Chen TY; Ma HW; Jin RR; Xu C; Hua HJ; Song GX; Zhang WM; Zhang ZH Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):553-558. PubMed ID: 28810296 [No Abstract] [Full Text] [Related]
6. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies. Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089 [TBL] [Abstract][Full Text] [Related]
7. A novel autophagy-related lncRNA survival model for lung adenocarcinoma. Wu L; Wen Z; Song Y; Wang L J Cell Mol Med; 2021 Jun; 25(12):5681-5690. PubMed ID: 33987935 [TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of a Proliferation-Associated Score Model Predicting Survival in Lung Adenocarcinomas. Bian Y; Sui Q; Bi G; Zheng Y; Zhao M; Yao G; Xue L; Zhang Y; Fan H Dis Markers; 2021; 2021():3219594. PubMed ID: 34721732 [TBL] [Abstract][Full Text] [Related]
9. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma. Wang H; Wei C; Pan P; Yuan F; Cheng J Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305 [TBL] [Abstract][Full Text] [Related]
10. Eight-gene signature predicts recurrence in lung adenocarcinoma. Zhang Y; Fan Q; Guo Y; Zhu K Cancer Biomark; 2020; 28(4):447-457. PubMed ID: 32508318 [TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature. Sui J; Yang S; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G J Cell Biochem; 2019 Jan; 120(1):705-714. PubMed ID: 30125988 [TBL] [Abstract][Full Text] [Related]
12. Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma. Zengin T; Önal-Süzek T BMC Bioinformatics; 2020 Sep; 21(Suppl 14):368. PubMed ID: 32998690 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma. Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085 [No Abstract] [Full Text] [Related]
14. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer. Tian WJ; Liu SS; Li BR Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552 [TBL] [Abstract][Full Text] [Related]
15. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma]. Zhou J; Wang X; Li Z; Jiang R Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900 [TBL] [Abstract][Full Text] [Related]
16. Density of tumor-infiltrating NK and Treg cells is associated with 5 years progression-free and overall survival in resected lung adenocarcinoma. Szentkereszty M; Ladányi A; Gálffy G; Tóvári J; Losonczy G Lung Cancer; 2024 Jun; 192():107824. PubMed ID: 38761665 [TBL] [Abstract][Full Text] [Related]
17. [Establishment of artificial neural network model for predicting lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer]. Xue Z; Lu J; Lin J; Huang CM; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Zheng CH Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):327-335. PubMed ID: 35461201 [No Abstract] [Full Text] [Related]
18. BACH1: A Potential Predictor of Survival in Early-Stage Lung Adenocarcinoma. Zhou J; Liu Z; Zhang H; Lei T; Liu J; Zhao Y; Yao Y; Song Q Oxid Med Cell Longev; 2022; 2022():3921095. PubMed ID: 35035660 [TBL] [Abstract][Full Text] [Related]
19. Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis. Zhang MY; Liu XX; Li H; Li R; Liu X; Qu YQ Int J Med Sci; 2018; 15(14):1676-1685. PubMed ID: 30588191 [No Abstract] [Full Text] [Related]
20. Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma. Zhang L; Zhang Z; Yu Z J Transl Med; 2019 Dec; 17(1):423. PubMed ID: 31847905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]